Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (151-160 of 802) with videos related to

Pageof 81
Sort By:
Current Opinion in Pulmonary Medicine|January 30, 2004
Macrolide and occult infection in asthmaMario Cazzola, Maria Gabriella Matera, Francesco Blasi
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2017
Doxofylline is not just another theophylline!Maria Gabriella Matera, Clive Page, Mario Cazzola
Therapeutic Advances in Respiratory Disease|May 16, 2009
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasoneMario Cazzola, Paolo Noschese, Felice Di Perna
Expert Opinion on Pharmacotherapy|March 28, 2014
Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|May 17, 2003
Novelties in the field of antimicrobial compounds for the treatment of lower respiratory tract infectionsMario Cazzola, Alessandro Sanduzzi, Maria Gabriella Matera
Current Opinion in Pulmonary Medicine|October 10, 2009
Novel bronchodilators in asthmaMario Cazzola, Andrea Segreti, Maria G Matera
Respiratory Medicine|August 31, 2025
Comorbidities as treatable traits of chronic airway diseasesMario Cazzola, Nicola A Hanania, Paola Rogliani
Expert Opinion on Pharmacotherapy|June 4, 2008
Long-acting beta(2) agonists in asthma and allergic rhinitisMaria Gabriella Matera, Giacomo Curradi, Mario Cazzola
Expert Opinion on Investigational Drugs|July 19, 2005
Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary diseaseMario Cazzola, Maria Gabriella Matera, Jan Lötvall
Drug Design, Development and Therapy|October 22, 2013
New developments in the combination treatment of COPD: focus on umeclidinium/vilanterolMario Cazzola, Andrea Segreti, Maria Gabriella Matera
Pageof 81

Showing results (151-160 of 802) with videos related to

Sort By:
Pageof 81
Current Opinion in Pulmonary Medicine|January 30, 2004
Macrolide and occult infection in asthmaMario Cazzola, Maria Gabriella Matera, Francesco Blasi
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2017
Doxofylline is not just another theophylline!Maria Gabriella Matera, Clive Page, Mario Cazzola
Therapeutic Advances in Respiratory Disease|May 16, 2009
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasoneMario Cazzola, Paolo Noschese, Felice Di Perna
Expert Opinion on Pharmacotherapy|March 28, 2014
Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|May 17, 2003
Novelties in the field of antimicrobial compounds for the treatment of lower respiratory tract infectionsMario Cazzola, Alessandro Sanduzzi, Maria Gabriella Matera
Current Opinion in Pulmonary Medicine|October 10, 2009
Novel bronchodilators in asthmaMario Cazzola, Andrea Segreti, Maria G Matera
Respiratory Medicine|August 31, 2025
Comorbidities as treatable traits of chronic airway diseasesMario Cazzola, Nicola A Hanania, Paola Rogliani
Expert Opinion on Pharmacotherapy|June 4, 2008
Long-acting beta(2) agonists in asthma and allergic rhinitisMaria Gabriella Matera, Giacomo Curradi, Mario Cazzola
Expert Opinion on Investigational Drugs|July 19, 2005
Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary diseaseMario Cazzola, Maria Gabriella Matera, Jan Lötvall
Drug Design, Development and Therapy|October 22, 2013
New developments in the combination treatment of COPD: focus on umeclidinium/vilanterolMario Cazzola, Andrea Segreti, Maria Gabriella Matera
Pageof 81